Real-World Corticosteroid Utilization Patterns in Patients with Metastatic Castration-Resistant Prostate Cancer in 2 Large US Administrative Claims Databases

BACKGROUND: Prostate cancer is the most common noncutaneous malignancy in men in the United States. Patients with metastatic castration-resistant prostate cancer (mCRPC) may be treated with secondary hormonal therapy or with chemotherapy, and potentially with concomitant corticosteroids. Corticoster...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lafeuille, Marie-Hélène, Gravel, Jonathan, Grittner, Amanda, Lefebvre, Patrick, Ellis, Lorie, McKenzie, R. Scott
Format: Artigo
Idioma:Inglês
Publicat: Engage Healthcare Communications, LLC 2013
Matèries:
Business
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4031721/
https://ncbi.nlm.nih.gov/pubmed/24991366
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars